Eicosanoids: An emerging role in dendritic cell biology

Archivum Immunologiae et Therapiae Experimentalis

Volumn 52, Issue 1, 2004, Pages 1-5

  Harizi, Hedi ^a,b   Gualde, Norbert ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS Bordeaux Segalen University   (France)

Author keywords

DC; Eicosanoids; Immunomodulation

Indexed keywords

ARACHIDONIC ACID; ICOSANOID; LEUKOTRIENE B4; LEUKOTRIENE DERIVATIVE; LIPID; PROSTAGLANDIN D2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN J2;

ANTIGEN PRESENTING CELL; BONE MARROW CELL; CELL MATURATION; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; REVIEW; STEM CELL; SYSTEMATIC REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ARACHIDONIC ACID; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; DENDRITIC CELLS; EICOSANOIDS; HUMANS; LEUKOTRIENES; MACROPHAGES; PROSTAGLANDINS;

EID: 4844228958     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Aderem A. A., Cohen D. S., Rwight S. D. and Cohen Z. A. (1986): Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J. Exp. Med., 164, 165-179.
2. Angeli V., Faveeuw C., Roye O., Fontaine J., Teissier E., Capron A., Wołowczuk I., Capron M. and Trottein F. (2001): Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med., 193, 1135-1147.
3. Bachwich P. R., Chensue S. W., Larrick J.W. and Kunkel S. L. (1986): Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. Biochem. Biophys. Res. Commun., 14, 94-101.
4. Banchereau J. (1997): Dendritic cells: therapeutic potentials. Transfus. Sci., 18, 313-326.
5. Banchereau J., Briere F., Caux C., Lebeque S., Liu Y. J., Pulendran B. and Palucka K. (2000): Immunobiology of dendritic cells. Annu. Rev. Immunol., 18, 767-811.
6. Barrios-Rodiles M. and Chadee K. (1998): Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-γ in human macrophages. J. Immunol., 161, 2441-2448.
7. Bell D., Young J. W. and Banchereau J. (1999): Dendritic cells. Adv. Immunol., 72, 255-324.
8. Breyer R. M., Bagdassarian C. K., Myers S. A. and Breyer M. D. (2001): Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol., 41, 661-690.
9. Cella M., Engering A., Pinet V. and Lanzavecchia A. (1997): Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature, 388, 782-787.
10. Denizot Y., Dulery C., Trimoreau F., Desplat V. and Praloran V. (1998): Arachidonic acid and human bone marrow stromal cells. Biochim. Biophys. Acta, 27, 209-215.
11. Denizot Y., Trimoreau F., Dupuis F., Verger C. and Praloran V. (1995): PAF and haematopoiesis. III. Presence and metabolism of platelet-activating factor in human bone marrow. Biochim. Biophys. Acta, 1265, 55-60.
12. De Smedt T., Pajak B., Muraille E., Lespagnard L., Heinen E., De Baetselier P., Urbain, J., Leo O. and Moser M. (1996): Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med., 184, 1413-1424.
13. Gentille P. S. and Pelus L. M. (1987): Modulation of myelopoiesis by PGE2. Inhibition of granulocyte-monocyte progenitors (CFU-GM) cell cycle rate. Exp. Haematol., 15, 119-126.
14. Gentile P. S. and Pelus L. M. (1988): In vivo modulation of myelopoiesis by prostaglandin E2. IV. Prostaglandin E2 induction of myelopoietic inhibitory activity. J. Immunol., 141, 2714-2720.
15. Goetzl E. J., An S. and Smith W. (1995): Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J., 9, 1051-1058.
16. Gosset P., Bureau F., Angeli V., Pichavant M., Faveeuw C., Tonnel A. B. and Trottein F. (2003): Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J. Immunol., 170, 4943-4952.
17. Granucci F., Zanoni I., Feau S. and Ricciardi-Castagnoli P. (2003): Dendritic cell regulation of immune response: a new role of interleukin-2 at the intersection of the innate and adaptive immunity. EMBO J., 22, 2548-2551.
18. Harizi H. and Gualde N. (2002): Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells. Prostaglandins Leukot. Essent. Fatty Acids, 66, 459-466.
19. Harizi H., Grosset C. and Gualde N. (2003): Prostaglandin E2 modulates dendritic cell functions via EP2 and EP4 receptor subtypes. J. Leukoc. Biol., 73, 756-763.
20. Harizi H., Juzan M., Grosset C., Rashedi M. and Gualde N. (2001): Dendritic cells issued in vitro from bone marrow produce PGE2 that contributes to the immunomodulation induced by antigen-presenting cells. Cell. Immunol., 209, 19-28.
21. Harizi H., Juzan M., Moreau J.-F. and Gualde N. (2003): Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism. J. Immunol., 170, 139-146.
22. Harizi H., Juzan M., Pitard V., Moreau J.-F. and Gualde N. (2002): Cyclooxygenase-2-issued PGE2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol., 168, 2255-2263.
23. Harris S. G., Padilla J., Koumas L., Ray D. and Phipps R. P. (2002): Prostaglandins as mediators of immunity. Trends Immunol., 23, 144-150.
24. Homaidan F. R., Chakroun I., Haidar H. A. and EL-Sabban M. (2002): Protein regulators of eicosanoid synthesis: role in inflammation. Curr. Protein Pept. Sci., 3, 467-484.
25. Humes J. L., Bonney R. J., Pelus L., Dahlgren M. E., Sadowski S. J. and Kuehl F. A. jr. (1997): Macrophage synthesis and release of prostaglandins in response to inflammatory stimuli. Nature, 269, 149-151.
26. Hwang O. (1989): Essential fatty acid and immune response. FASEB J., 3, 2052-2064.
27. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J. and Enk A.H. (1997): Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol., 27, 3135-3142.
28. Kalinski P., Hilkens C. M., Snijdewint F. G. and Kapsenberg M. L. (1997): IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol., 159, 28-36.
29. Kalinski P., Schuitemaker J. H., Hilkens C. M. and Kapsenberg M. L. (1998): Prostaglandin E2 induces the final maturation of IL-12-deficient CDla+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol., 161, 2804-2809.
30. Kalinski P., Vieira P. L., Schuitemaker J. H., de Jong E. C. and Kapsenberg M. L. (2001): Prostaglandin E2 is a selective inducer of interleukin-12p40 production and an inhibitor of IL-12p70 heterodimer. Blood, 97, 3466-3469.
31. Kambayashi T., Wallin R. P. and Ljunggren H. G. (2001): cAMP-elevating agents suppress dendritic cell function. J. Leukoc. Biol., 70, 903-910.
32. Luft T., Jefford M., Luetjens P., Toy T., Hochrein H., Masterman K. A., Maliszewski C., Shortman K., Cebon J. and Maraskovsky E. (2002): Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets. Blood, 100, 1362-1372.
33. Meja K. K., Barnes P. J. and Giembycz M. A. (1997): Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-α generation. Br. J. Pharmacol., 122, 149-157.
34. Nakayama Y., Shindo T., Akihama T. and Miura A. B. (1984): Prostaglandin E2 production by human bone marrow cells: a comparison with peripheral blood mononuclear cells. J. Exp. Med., 144, 417-423.
35. Narumiya S., Sugimoto Y. and Ushikubi F. (1999): Prostanoid receptors: structures, properties and functions. Physiol. Rev., 79, 1193-1226.
36. Nathan C. F. (1987): Secretory products of macrophages. J. Clin. Invest., 79, 319-327.
37. Pierre P., Turley S. J., Gatti E., Hul, M., Meltzer J., Mirza A., Inaba K., Steinman R. M. and Mellman I. (1997): Developmental regulation of MHC class II in mouse dendritic cells. Nature, 388, 787-792.
38. Robbiani D. F., Finch R. A., Jager D., Muller W. A., Sartorelli R. C. and Randolph G. J. (2000): The leukotriene C4 transporter regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell, 103, 757-768.
39. Sallusto F., Cella M., Danielli C. and Lanzavecchia A. (1995): Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med., 182, 389-400.
40. Scandella E., Men Y., Gillessen S., Forster R. and Groettrup M. (2002): Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood, 100, 1354-1361.
41. Shibata Y., Burdick M. K., Bjorkman D. R. and Volkman A. A. (1997): Regulatory role of PGE2-activated adhesion molecules in myelopoiesis. Adv. Exp. Med. Biol., 400B, 741-749.
42. Spanbroek R., Hildner M., Steinhilber D., Fusenig N., Yoneda K., Radmark O., Samuelsson B. and Habenicht A. J. R. (2000): 5-Lipoxygenase expression in dendritic cells generated from CD34+ hematopoietic progenitors and in lymphoid organs. Blood, 96, 3857-3865.
43. Spanbroek R., Stark H. J., Jassen-Timmen U., Kraft S., Hilder M., Andl T., Bosch F. X., Fusenig N. E., Bieber T., Radmark O., Samuelsson B. and Habenicht A. J. (1998): 5-Lipoxygenase expression in Langerhans cells of normal human epidermis. Proc. Natl. Acad. Sci. USA, 95, 663-668.
44. Takayama K., Garcia-Gardena G., Sulkhova G. K., Gomander J., Gimbrone M. A. jr. and Libby P. (2002): Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J. Biol. Chem., 277, 44147-44154.
45. Tanner W. G., Welbom M. B. and Shepherd V. L. (1992): Tumor necrosis factor-α and interleukin-1α synergistically enhance phorbol myristate acetate-induced superoxide production by rat bone marrow-derived macrophages. Am. J. Resp. Cell. Mol. Biol., 7, 379-384.
46. Tilley S. L., Coffman T. M. and Koller B. H. (2001): Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest., 108, 15-23.
47. Trinchieri G. (1995): Interleukin-12: a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol., 13, 251-273.
48. Van der Pouw Kraan T. C., Boeije L. C., Smeenk R. J., Wijdenes J. and Aarden L. A. (1995): Prostaglandin E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med., 181, 775-779.
49. Watts C. (1997): Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol., 15, 821-850.
50. Whittaker D. S., Bahjat K. S., Moldawer L. L. and Clare-Salzler M. J. (2000): Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2 mediated prostanoid production. J. Immunol., 165, 4298-4304.
51. Williams J. A. and Shacter E. (1997): Regulation of macrophage cytokine production by prostaglandin E2: distinct roles of cyclooxygenase-1 and -2. J. Biol. Chem., 272, 25693-25699.
52. Yang L., Yagamata N., Yadav R., Brandon S., Courtney R. L., Morrow D. J., Shyr Y., Bothby M., Joyce S., Carbone P. D. and Breyer R. M. (2003): Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the EP2 receptor. J. Clin. Invest., 111, 727-735.